ArticleJournal of neuro-oncology2023

The outcome of central nervous system hemangioblastomas in Von Hippel-Lindau (VHL) disease treated with belzutifan: a single-institution retrospective experience.

Aroosa Zamarud et al.PubMed ↗Publisher ↗

No numbers read from the abstract.